Showing results (641-650 of 706) with videos related to
Sort By:
Pageof 71
Journal of Lipid Research|November 12, 2010
Pnpla3/Adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndromeMahesh K Basantani, Mitch T Sitnick, Lingzhi Cai, et al.American Journal of Physiology. Lung Cellular and Molecular Physiology|April 19, 2022
Imatinib alleviates lung injury and prolongs survival in ventilated ratsYi Xin, Maurizio Cereda, Nadir Yehya, et al.Pediatrics|May 28, 2014
Reducing injury risk from body checking in boys' youth ice hockey, Alison Brooks, Keith J Loud, et al.Life Science Alliance|August 12, 2024
Neutrophil-avid nanocarrier uptake by STAT3 dominant-negative hyper-IgE syndrome patient neutrophilsKathryn M Rubey, Alexandra Freeman, Alexander R Mukhitov, et al.Proceedings of the National Academy of Sciences of the United States of America|March 4, 2000
In vitro cloning of complex mixtures of DNA on microbeads: physical separation of differentially expressed cDNAsS Brenner, S R Williams, E H Vermaas, et al.European Heart Journal|August 17, 1999
Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) RegistryB A Bart, G Ertl, P Held, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|March 16, 2019
Combining vascular targeting and the local first pass provides 100-fold higher uptake of ICAM-1-targeted vs untargeted nanocarriers in the inflamed brainOscar A Marcos-Contreras, Jacob S Brenner, Raisa Y Kiseleva, et al.Pediatrics|June 2, 2010
Athletic participation by children and adolescents who have systemic hypertensionTeri M McCambridge, Holly J Benjamin, Joel S Brenner, et al.Advanced Nanobiomed Research|June 2, 2023
Mechanisms by Which Liposomes Improve Inhaled Drug Delivery for Alveolar DiseasesLaura T Ferguson, Xiaonan Ma, Jacob W Myerson, et al.American Heart Journal|March 31, 2000
Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitorsC B Granger, G Ertl, J Kuch, et al.Pageof 71